(Q74447776)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11530749%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

review article

1 reference

title

[Pulmonary diffusion of antibiotics. Critical analysis of the literature] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11530749%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11530749%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

B Allaouchiche

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11530749%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 August 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11530749%20AND%20SRC:MED&resulttype=core&format=json

French Annals of Anesthesia and Reanimation

10 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11530749%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11530749%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11530749%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

612-630

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11530749%20AND%20SRC:MED&resulttype=core&format=json

Pulmonary disposition of antimicrobial agents: methodological considerations

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0750-7658%2801%2900439-7

7 January 2021

Pulmonary metabolism of foreign compounds: its role in metabolic activation

1 reference

https://api.crossref.org/works/10.1016%2FS0750-7658%2801%2900439-7

7 January 2021

Antibiotic penetration into lung tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0750-7658%2801%2900439-7

7 January 2021

The site concentrations of antimicrobial agents in the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0750-7658%2801%2900439-7

7 January 2021

Role of beta-lactamases in the response of pulmonary infections to amoxycillin/clavulanate

1 reference

https://api.crossref.org/works/10.1016%2FS0750-7658%2801%2900439-7

7 January 2021

Pharmacokinetics of antimicrobial agents in the respiratory tract.

1 reference

https://api.crossref.org/works/10.1016%2FS0750-7658%2801%2900439-7

7 January 2021

Intrapulmonary concentrations of antimicrobial agents

1 reference

https://api.crossref.org/works/10.1016%2FS0750-7658%2801%2900439-7

7 January 2021

Antibiotic tissue penetration and its relevance: models of tissue penetration and their meaning

1 reference

https://api.crossref.org/works/10.1016%2FS0750-7658%2801%2900439-7

7 January 2021

Microlavage: a technique for determining the volume of epithelial lining fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0750-7658%2801%2900439-7

7 January 2021

Predicting the efficacy of antimicrobial agents in respiratory infections--is tissue concentration a valid measure?

1 reference

https://api.crossref.org/works/10.1016%2FS0750-7658%2801%2900439-7

7 January 2021

Evaluation of the penetration of ciprofloxacin and amoxycillin into the bronchial mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS0750-7658%2801%2900439-7

7 January 2021

Levels of erythromycin in pulmonary tissue and bronchial mucus compared to those of amoxycillin

1 reference

https://api.crossref.org/works/10.1016%2FS0750-7658%2801%2900439-7

7 January 2021

Concentration of amoxycillin and clavulanate in lung compartments in adults without pulmonary infection

1 reference

https://api.crossref.org/works/10.1016%2FS0750-7658%2801%2900439-7

7 January 2021

D1-2: A Novel Method for Calculating Aggregate Counts While Censoring Small Cells in Multi-site Studies

1 reference

https://api.crossref.org/works/10.1016%2FS0750-7658%2801%2900439-7

7 January 2021

Penetration of amoxycillin/clavulanic acid into bronchial mucosa with different dosing regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0750-7658%2801%2900439-7

7 January 2021

Penetration into lung tissue after intravenous administration of amoxycillin/clavulanate

1 reference

https://api.crossref.org/works/10.1016%2FS0750-7658%2801%2900439-7

7 January 2021

Penetration of piperacillin into bronchial mucosa and sputum

1 reference

https://api.crossref.org/works/10.1016%2FS0750-7658%2801%2900439-7

7 January 2021

Imipenem kinetics in serum, lung tissue and pericardial fluid in patients undergoing thoracotomy

1 reference

https://api.crossref.org/works/10.1016%2FS0750-7658%2801%2900439-7

7 January 2021

Penetration of cefazolin into pleural fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0750-7658%2801%2900439-7

7 January 2021

Penetration of cefuroxime and ceftazidime into human lungs

1 reference

https://api.crossref.org/works/10.1016%2FS0750-7658%2801%2900439-7

7 January 2021

Single-dose intrapulmonary pharmacokinetics of azithromycin, clarithromycin, ciprofloxacin, and cefuroxime in volunteer subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0750-7658%2801%2900439-7

7 January 2021

Penetration of cefuroxime and doxycycline into the pleural fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0750-7658%2801%2900439-7

7 January 2021

New concepts in the pulmonary disposition of antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0750-7658%2801%2900439-7

7 January 2021

Comparative concentrations of cefoxitin in human lungs and sera

1 reference

https://api.crossref.org/works/10.1016%2FS0750-7658%2801%2900439-7

7 January 2021

Concentrations of cefixime in bronchial mucosa and sputum after three oral multiple dose regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0750-7658%2801%2900439-7

7 January 2021

Penetration of cefpodoxime proxetil in lung parenchyma and epithelial lining fluid of noninfected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0750-7658%2801%2900439-7

7 January 2021

Concentrations of Ceftriaxone in Serum and Lung Tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0750-7658%2801%2900439-7

7 January 2021

Pharmacokinetics and tissue penetration of a single dose of ceftriaxone (1,000 milligrams intravenously) for antibiotic prophylaxis in thoracic surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0750-7658%2801%2900439-7

7 January 2021

Pharmacokinetics and tissue penetration of ceftazidime: studies on lymph, aqueous humour, skin blister, cerebrospinal and pleural fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0750-7658%2801%2900439-7

7 January 2021

Pulmonary Penetration of Ceftazidime

1 reference

https://api.crossref.org/works/10.1016%2FS0750-7658%2801%2900439-7

7 January 2021

The penetration of cefpirome into the potential sites of pulmonary infection

1 reference

https://api.crossref.org/works/10.1016%2FS0750-7658%2801%2900439-7

7 January 2021

Penetration of aminoglycosides in uninfected pleural exudates and in pleural empyemas

1 reference

https://api.crossref.org/works/10.1016%2FS0750-7658%2801%2900439-7

7 January 2021

Tobramycin penetration into epithelial lining fluid of patients with pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0750-7658%2801%2900439-7

7 January 2021

Tissue penetration and pulmonary disposition of tobramycin

1 reference

https://api.crossref.org/works/10.1016%2FS0750-7658%2801%2900439-7

7 January 2021

Accumulation of pefloxacin in the lower respiratory tract demonstrated by bronchoalveolar lavage.

1 reference

https://api.crossref.org/works/10.1016%2FS0750-7658%2801%2900439-7

7 January 2021

Diffusion of ofloxacin into human lung tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0750-7658%2801%2900439-7

7 January 2021

Bronchial penetration of ofloxacin after single and multiple oral dosage

1 reference

https://api.crossref.org/works/10.1016%2FS0750-7658%2801%2900439-7

7 January 2021

Reproducibility of the measurement of ciprofloxacin concentration in bronchial mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS0750-7658%2801%2900439-7

7 January 2021

Respiratory tract penetration of ciprofloxacin

1 reference

https://api.crossref.org/works/10.1016%2FS0750-7658%2801%2900439-7

7 January 2021

Steady-state pharmacokinetics of ciprofloxacin in plasma from patients with nosocomial pneumonia: penetration of the bronchial mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS0750-7658%2801%2900439-7

7 January 2021

Ciprofloxacin concentrations in lung tissue following a single 400 mg intravenous dose

1 reference

https://api.crossref.org/works/10.1016%2FS0750-7658%2801%2900439-7

7 January 2021

Penetration of ciprofloxacin into human pleural fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0750-7658%2801%2900439-7

7 January 2021

Penetration of sparfloxacin and ciprofloxacin into alveolar macrophages, epithelial lining fluid, and polymorphonuclear leucocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0750-7658%2801%2900439-7

7 January 2021

Intrapulmonary pharmacokinetics of clarithromycin and of erythromycin

1 reference

https://api.crossref.org/works/10.1016%2FS0750-7658%2801%2900439-7

7 January 2021

Pulmonary disposition of roxithromycin (RU 28965), a new macrolide antibiotic

1 reference

https://api.crossref.org/works/10.1016%2FS0750-7658%2801%2900439-7

7 January 2021

Penetration of clarithromycin into lung tissues from patients undergoing lung resection

1 reference

https://api.crossref.org/works/10.1016%2FS0750-7658%2801%2900439-7

7 January 2021

The diffusion of clarithromycin and roxithromycin into nasal mucosa, tonsil and lung in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0750-7658%2801%2900439-7

7 January 2021

The levels of clarithromycin and its 14-hydroxy metabolite in the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0750-7658%2801%2900439-7

7 January 2021

High and prolonged pulmonary tissue concentrations of azithromycin following a single oral dose.

1 reference

https://api.crossref.org/works/10.1016%2FS0750-7658%2801%2900439-7

7 January 2021

Intrapulmonary pharmacokinetics of azithromycin in healthy volunteers given five oral doses

1 reference

https://api.crossref.org/works/10.1016%2FS0750-7658%2801%2900439-7

7 January 2021

Pulmonary penetration of dirithromycin in patients suffering from acute exacerbation of chronic bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS0750-7658%2801%2900439-7

7 January 2021

Penetration of vancomycin into human lung tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0750-7658%2801%2900439-7

7 January 2021

Analysis of vancomycin entry into pulmonary lining fluid by bronchoalveolar lavage in critically ill patients

1 reference

https://api.crossref.org/works/10.1016%2FS0750-7658%2801%2900439-7

7 January 2021

Tissue levels of doxycycline in the human lung and pleura

1 reference

https://api.crossref.org/works/10.1016%2FS0750-7658%2801%2900439-7

7 January 2021

The inhibitory quotient. A method for interpreting minimum inhibitory concentration data

1 reference

https://api.crossref.org/works/10.1016%2FS0750-7658%2801%2900439-7

7 January 2021

10.1016/S0750-7658(01)00439-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11530749%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference